Health Effects Assessment for Polycyclic Aromatic Hydrocarbons (PAHs)

Abstract

The document represents a brief, quantitatively oriented scientific summary of health effects data. It was developed by the Environmental Criteria and Assessment Office to assist the Office of Emergency and Remedial Response in establishing chemical-specific health-related goals of remedial actions. If applicable, chemical-specific subchronic and chronic toxicity interim acceptable intakes are determined for systemic toxicants, or q(sub 1)* values are determined for carcinogens for both oral and inhalation routes. A q(sub 1)* was determined for polycyclic aromatic hydrocarbons based on both oral and inhalation exposure. These estimates are based on benzo(a)pyrene, the most potent constituent in PAH containing mixtures identified to date. The text provides information concerning the limitations of these estimates.

Citation

U.S. EPA. Health Effects Assessment for Polycyclic Aromatic Hydrocarbons (PAHs). U.S. Environmental Protection Agency, Washington, D.C., EPA/540/1-86/013 (NTIS PB86134244).

Additional Information

See also PB81-117806, PB86-134236 and PB86-134251. repared in cooperation with Syracuse Research Corp., NY.

• HEALTH EFFECTS ASSESSMENT FOR POLYCYCLIC AROMATIC HYDROCARBONS (PAHS)